These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 2996686)

  • 1. Antiviral therapy in the immunocompromised patient.
    Prentice HG; Hann IM
    Br Med Bull; 1985 Oct; 41(4):367-73. PubMed ID: 2996686
    [No Abstract]   [Full Text] [Related]  

  • 2. The pathogenesis of AIDS: lessons learned from other medical conditions.
    Griffiths PD; Whitley RD
    Infect Agents Dis; 1996 Oct; 5(4):231-9. PubMed ID: 8884368
    [No Abstract]   [Full Text] [Related]  

  • 3. [Pathogenesis and therapy of persistent infections associated with immunodeficiency syndromes].
    Votiakov VI; Kolomiets AG
    Klin Med (Mosk); 1991 May; 69(5):29-37. PubMed ID: 1649934
    [No Abstract]   [Full Text] [Related]  

  • 4. [Therapy of infections caused by opportunistic pathogens: viruses and parasites].
    Aznar J
    Enferm Infecc Microbiol Clin; 1989; 7 Suppl 1():56-61. PubMed ID: 2562308
    [No Abstract]   [Full Text] [Related]  

  • 5. Resistance of viruses to antiviral drugs.
    Freifeld AG; Ostrove JM
    Annu Rev Med; 1991; 42():247-59. PubMed ID: 1852148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advanced therapeutic and prophylactic strategies for Epstein-Barr virus infection in immunocompromised patients.
    Okano M; Gross TG
    Expert Rev Anti Infect Ther; 2007 Jun; 5(3):403-13. PubMed ID: 17547505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Development in and role of antiviral agents].
    Lange JM; van der Noordaa J
    Ned Tijdschr Geneeskd; 1992 May; 136(20):958-64. PubMed ID: 1317510
    [No Abstract]   [Full Text] [Related]  

  • 8. Epstein-Barr viral infection and posttransplantation lymphoproliferative disorders.
    Rustgi VK
    Liver Transpl Surg; 1995 Sep; 1(5 Suppl 1):100-8. PubMed ID: 9346606
    [No Abstract]   [Full Text] [Related]  

  • 9. Tomorrow's challenges for herpesvirus management: potential applications of valacyclovir.
    Griffiths PD
    J Infect Dis; 2002 Oct; 186 Suppl 1():S131-7. PubMed ID: 12353198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of quantitative PCR to predict onset of Epstein-Barr viral infection and post-transplant lymphoproliferative disease after intestinal transplantation in children.
    Green M; Reyes J; Jabbour N; Yunis E; Putnam P; Todo S; Rowe D
    Transplant Proc; 1996 Oct; 28(5):2759-60. PubMed ID: 8908044
    [No Abstract]   [Full Text] [Related]  

  • 11. Current leads in antiviral chemotherapy.
    De Clercq E
    J Antimicrob Chemother; 1986 Apr; 17(4):399-402. PubMed ID: 3011723
    [No Abstract]   [Full Text] [Related]  

  • 12. [Herpesvirus infections--indications for chemotherapy in dermato-venereology].
    Gross GE; Schumann J
    Hautarzt; 1990 Nov; 41(11):591-601. PubMed ID: 1703519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary disease in the immunocompromised child.
    Pennington DJ; Lonergan GJ; Benya EC
    J Thorac Imaging; 1999 Jan; 14(1):37-50. PubMed ID: 9894952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Viral infections in the granulocytopenic patient].
    Moroni M; Esposito R
    Haematologica; 1989 Oct; 74(5 Suppl):310-9. PubMed ID: 2556334
    [No Abstract]   [Full Text] [Related]  

  • 15. [Future prospects of valacyclovir in treating and preventing herpesviridae infections in immunosuppressed patients].
    Raffi F
    Presse Med; 1997 Jan; 26 Suppl 1():19-21. PubMed ID: 9082437
    [No Abstract]   [Full Text] [Related]  

  • 16. [Neoplasia in lung transplants].
    Blanco Aparicio M; Montero Martínez C
    Arch Bronconeumol; 2009 Aug; 45(8):363-5. PubMed ID: 19592149
    [No Abstract]   [Full Text] [Related]  

  • 17. Clonality of EBV-induced lymphoproliferative diseases in immune-deficient patients.
    Purtilo DT
    N Engl J Med; 1984 Jul; 311(3):191-2. PubMed ID: 6330551
    [No Abstract]   [Full Text] [Related]  

  • 18. Viral prophylaxis in organ transplant patients.
    Slifkin M; Doron S; Snydman DR
    Drugs; 2004; 64(24):2763-92. PubMed ID: 15563248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Foscarnet therapy for AIDS-related opportunistic herpesvirus infections.
    Jacobson MA
    AIDS Clin Rev; 1992; ():173-89. PubMed ID: 1318736
    [No Abstract]   [Full Text] [Related]  

  • 20. Antivirals in the transplant setting.
    Griffiths PD
    Antiviral Res; 2006 Sep; 71(2-3):192-200. PubMed ID: 16793148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.